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http://dx.doi.org/10.1016/j.cell.2014.09.016Although sometimes considered a ‘‘house-keeping’’ function, multiple aspects of protein synthesis
are regulated differently among somatic cells, including stem cells, and can be modulated in a cell-
type-specific manner. These differences are required to establish and maintain differences in cell
identity, cell function, tissue homeostasis, and tumor suppression.Introduction
Much of what is known about protein synthesis has been learned
from studies in yeast and mammalian cell lines (Hinnebusch and
Lorsch, 2012; Lorsch and Dever, 2010). Moreover, analysis of
uncultured tissues or tumors provides an aggregate picture of
protein synthesis across the tissue without revealing differences
among individual cells. Nonetheless, it is clear that protein syn-
thesis differs among mammalian somatic cells. For instance,
cells of the exocrine pancreas display some of the highest rates
of protein synthesis of any adult cell type (Case, 1978; Logsdon
and Ji, 2013). Protein production rates vary greatly among liver,
kidney, and muscle cells (Allfrey et al., 1953; Garlick, 1972; Gar-
lick et al., 1980; Garlick et al., 1991). Related cells within the same
lineage can also exhibit different rates of mRNA translation. For
example, in the immune system, primed T cells experience a
global attenuation of mRNA translation, which is subsequently
reversed upon restimulation (Scheu et al., 2006). However, we
are only beginning to appreciate the ways in which these differ-
ences in protein synthesis are necessary for tissue development
and homeostasis. This is because new approaches are making it
possible to more generally compare protein synthesis and its
regulation among different kinds of cells, revealing an unex-
pected richness in the biology.
Studies of stem cell function and tissue homeostasis offer the
opportunity to better understand differences in protein synthesis
among somatic cells and their physiological significance. The
balance between stem cell self-renewal and differentiation
must be tightly regulated: self-renewal without differentiation
leads to tumorigenesis while differentiation without self-renewal
depletes stem cells and tissue regenerative capacity. Great
effort has been invested in determining the transcriptional and
epigenetic networks that govern stem cell identity and function,
but gene expression programs are ultimately governed at the
level of mRNA translation (Schwanha¨usser et al., 2011). Cell-
type-specific differences in translation regulate development,
differentiation, and responses to stresses such as nutrient depri-
vation. Differences in the regulation of translation among cells
may actually help to establish and maintain differences in cell
identity and function.242 Cell 159, October 9, 2014 ª2014 Elsevier Inc.In this reviewwe focus on differences in the regulation of trans-
lation among cells and the physiological consequences. Some
well-characterized mechanisms that regulate differences in pro-
tein synthesis among cells, such as differences in microRNA
expression, arebeyond thescopeof this review.We focus instead
ondifferences in protein synthesis, protein stability, and ribosome
assembly among cells that are critical for tissue development and
homeostasis. Themechanisms that underlie thesedifferencesare
only beginning to be elucidated, but this is providing fundamental
new insights into development, tissue regeneration, and how
these processes go wrong in degenerative diseases and cancer.
Dynamic Protein Synthesis among Embryonic Cells
Cellular function depends upon proteostasis—appropriate regu-
lation of protein synthesis, protein folding, and protein degrada-
tion. Each of these are likely to exhibit cell-type-specific
differences in regulation that influence stem cell function, tissue
development, and homeostasis (Vilchez et al., 2014). However,
differences among somatic cells in protein folding and protein
degradationarenot aswell characterizedasdifferences inprotein
synthesis. We will thus focus mainly on protein synthesis even
though this is only one component of the proteostasis network.
Developmental studies have begun to reveal the extent to
which related cells exhibit functionally significant changes in pro-
tein synthesis as they differentiate. In mammals, these changes
can first be seen immediately after fertilization. Most proteins
exhibit 2-fold or greater changes in abundance as mouse em-
bryos transition from the one-cell to two-cell stage (Latham
et al., 1991). Studies of Drosophila have shown that the changes
in protein levels during the oocyte-to-embryo transition largely
occur at the level of translation, not transcription (Kronja et al.,
2014). Translational control mechanisms also help to promote
germ cell differentiation in Drosophila males (Insco et al., 2012).
Building upon these studies, the functional importance of differ-
ences in global protein production levels between undifferentiated
cells and their progeny has recently begun to come into focus.
mRNA translation changes on a global scale as mammalian
embryonic stem cells (ESCs) differentiate to form embryoid
bodies (Ingolia et al., 2011; Sampath et al., 2008). Continuously
Figure 1. Proteostasis Differs between Stem Cells and Their
Daughters
(A) Global protein translation levels remain low in embryonic stem cells (ESCs)
but increase as these cells differentiate to form embryoid bodies (EBs) (Ingolia
et al., 2011; Sampath et al., 2008). By contrast, the activity of protein degra-
dation mechanisms appears high in ESCs relative to EBs (Vilchez et al., 2012).
(B) Adult HSCs display low levels of global protein synthesis relative to
differentiating hematopoietic progenitor cells (Signer et al., 2014), and pro-
teotoxic stress response appears enhanced in umbilical cord blood (fetal)
HSCs (van Galen et al., 2014). Whether these trends in proteostasis regulatory
mechanisms will be seen in other stem cell populations remains unclear, but
keeping overall protein levels low in long-lived stem cell populations may
promote their fitness and longevity.dividing cells tend to synthesize more protein than nondividing
cells, but ESCs are distinct in that they maintain lower levels of
bulk mRNA translation and protein accumulation than their
differentiated progeny despite continuous cell division. ESCs
display a marked reduction in overall translational efficiency
(a lower fraction of mRNAs associate with actively translating
polysomes) relative to other cells. Induction of differentiation in-
creases global transcript levels and leads to more efficient
loading of mRNAs into polysomes, increasing protein synthesis
(Ingolia et al., 2011; Sampath et al., 2008).
Differences in protein synthesis among ESCs and their differ-
entiating progeny correlate with global translational changes. For
example, ESCs exhibit increased translation of upstream open
reading frames (uORFs) (Ingolia et al., 2011). uORFs form when
translation begins at initiation sites within the 50 UTRs of mRNAs
that are upstream of the initiation sites of recognized coding se-
quences. While uORFs can promote reinitiation at downstream
ORFs in specific cases, many act to decrease the translation
of the actual coding sequence by impeding scanning by the pre-
initiation complex (Barbosa et al., 2013). uORFs can be found in
49% of human transcripts and influence protein expression in a
variety of different contexts, including during stress responses
(Barbosa et al., 2013). Additional studies will be required to
determine whether the global change in uORF translation during
ESCdifferentiation commonly occurs during the differentiation of
other stem cells and whether it influences cell fate.Global regulation of protein degradation also controls protein
levels within ESCs and ESCmaintenance. Human ESCs express
high levels of the 19S proteasome subunit PSMD11 and exhibit
increased proteasome capacity relative to a variety of differenti-
ated progeny (Vilchez et al., 2012). Overexpression of PSMD11
increases proteasome capacity while decreased expression of
PSMD11 reduces ubiquitin-dependent protein degradation (Vil-
chez et al., 2012). Reduced proteasome activity reduces the
expression of pluripotency markers (Vilchez et al., 2012), sug-
gesting that ESCs depend on elevated proteasome activity for
their maintenance. Given that protein synthesis increases during
ESC differentiation (Ingolia et al., 2011; Sampath et al., 2008),
these findings suggest that low protein levels, achieved through
reduced translation and increased degradation, promote ESC
maintenance (Figure 1A).
Dynamic Protein Synthesis among
Stem/Progenitor Cells
Tounderstand the extent towhich differences in protein synthesis
among cells regulate normal tissue development and homeosta-
sis, it is necessary to study fetal and adult tissues in vivo. One lim-
itation has been the dependence upon pulsed metabolic labeling
to mark the synthesis of nascent polypeptides. Amino acid ana-
logs, such as methionine analogs, do not compete with endoge-
nous amino acids, limiting this approach to cells that survive and
proliferate in culture media depleted for the relevant amino acid
(Beatty et al., 2006). This has impeded efforts to directly measure
differences in protein synthesis among cells in vivo.Moreover, the
tissue culture environment differs from the in vivo environment in
many ways that influence cellular properties (Joseph and Morri-
son, 2005), including protein synthesis, at least in hematopoietic
stem cells (HSCs) (Signer et al., 2014). Other techniques for
measuring protein synthesis can be applied to uncultured cells,
but depend upon stable isotope labeling in vivo followed by
mass spectrometry (Kru¨ger et al., 2008; Xiao et al., 2008) or on
ribosome profiling (Li et al., 2014). These techniques have so far
only been used when cells are abundant and have not been
scaled down to analyze purified rare cell populations, such as so-
matic stem cells. Single-cell assays to measure protein synthesis
have been developed to look at the translation ofmRNAs contain-
ing specific translation regulatorymotifs (Han et al., 2014), but not
at global protein synthesis rates. Consequently, there is a general
need to develop more assays that enable quantitation of protein
synthesis in small numbers of cells in vivo.
A recent advance that facilitates quantitation of protein syn-
thesis in individual cells in vivo is the synthesis of O-propargyl-
puromycin (OP-Puro) (Liu et al., 2012). OP-Puro enters the
acceptor site of ribosomes and is covalently incorporated into
nascent polypeptide chains. Isolation and fixation of OP-Puro-
treated cells, followed by exposure to an azide-conjugated fluo-
rophore, leads to the fluorescination of all polypeptides that
incorporate OP-Puro via a click chemistry reaction (Liu et al.,
2012). The amount of protein synthesis per hour in individual
cells in vivo can then be quantitated by flow cytometry (Signer
et al., 2014).
Administration of OP-Puro in vivo shows that cells within
somatic stem cell lineages exhibit dynamic regulation of protein
synthesis. Adult HSCs exhibit less protein synthesis thanCell 159, October 9, 2014 ª2014 Elsevier Inc. 243
restricted hematopoietic progenitors (Signer et al., 2014).
We observed up to 10-fold differences in the amount of protein
synthesized per cell per hour in different hematopoietic stem/
progenitor cell populations. Although most adult HSCs are
quiescent, their lower levels of protein synthesis are independent
of cell-cycle status, cell size, and RNA content (Signer et al.,
2014). Genetic perturbations that modestly increase or decrease
protein synthesis both impair HSC function. A 30% decrease in
global protein synthesis in Rpl24Bst/+ mutant HSCs impairs their
ability to reconstitute the hematopoietic system of irradiated
mice. Likewise, increasing protein synthesis by deleting the
PI3K pathway inhibitor Pten depletes HSCs and promotes leu-
kemia development (Signer et al., 2014; Yilmaz et al., 2006).
Introducing the Rpl24Bst/+ mutation onto the Pten-deficient
background rescues both of these phenotypes, demonstrating
that PTEN maintains HSCs and suppresses leukemia mainly by
attenuating protein synthesis. Thus, HSCs and restricted he-
matopoietic progenitors synthesize different amounts of protein
per hour, and these differences are necessary for normal HSC
function.
Experimental interventions or mutations that reduce protein
synthesis extend lifespan in an evolutionarily conserved manner
(reviewed in Taylor and Dillin, 2011). This has been proposed
to occur at least partly because reduced protein synthesis in-
creases protein quality and reduces the burden imposed on
the protein-folding chaperone system by misfolded protein ag-
gregates. Certain long-lived mitotic cells, including some stem
cells, may maintain proteome quality by limiting protein synthe-
sis (Signer et al., 2014) or increasing proteasome activity (Vilchez
et al., 2012, 2014). The increased longevity associated with
decreased protein synthesis may partly reflect the increased
fitness of certain mitotic cells or increased tissue regenerative
capacity during aging as a consequence of reduced proteotoxic
stress, though this has not yet been tested.
Proteotoxic stress occurs under physiological conditions,
such as in pancreatic b cells that increase protein synthesis to
produce insulin in response to blood glucose spikes (Back
et al., 2009). Proteotoxic stress reduces protein synthesis by
inhibiting mRNA translation, typically at the level of initiation.
However, proteotoxic stress can also pause ribosomes during
elongation (Liu et al., 2013). This pausing typically occurs at sites
near where the nascent polypeptide chain emerges from the
ribosome and depends on the activity of various chaperone pro-
teins. Given the cell-specific differences in the expression and
activity of various chaperones, the response to proteotoxic
stress likely varies from cell to cell (Morimoto, 2008). Human
cord blood HSCs are particularly sensitive to proteotoxic stress,
undergoing apoptosis in response to a PERK-mediated unfolded
protein response (van Galen et al., 2014). The data suggest that
protein misfolding influences HSC function under physiological
conditions and support the idea that hematopoietic cells vary
in their sensitivity to proteotoxic stress.
TORC1 Regulates Stem Cells through Protein Synthesis
mTORC1 signaling represents a major mechanism by which
cells integrate nutrient availability, growth factor signaling, and
developmental cues to regulate protein synthesis (Figure 2A)
(Laplante and Sabatini, 2012). mTORC1 activation promotes244 Cell 159, October 9, 2014 ª2014 Elsevier Inc.protein synthesis through inhibition of 4E-BPs and activation of
S6K1, which acts on a number of translation initiation proteins
and other factors involved in translational elongation and ribo-
some biogenesis (Browne and Proud, 2002; Ma and Blenis,
2009; Mayer et al., 2004; Shahbazian et al., 2006) (Figure 2B).
The importance of mTORC1-mediated regulation of transla-
tion initiation during development has recently begun to emerge.
For example, increases in protein synthesis that occur during
early sea urchin embryogenesis correlate with decreased inhibi-
tion of eIF4E by 4E-BP as a consequence of increased 4E-BP
degradation (Cormier et al., 2001; Salau¨n et al., 2003). The in-
crease in 4E-BP degradation is blocked by rapamycin treatment,
suggesting that it reflects mTORC1 signaling. Phosphorylated
4E-BP1 levels increase as ESCs differentiate into EBs, poten-
tially explaining the increase in protein synthesis in EBs (Sam-
path et al., 2008). While loss of S6K1 has little or no effect on
the viability and proliferation of ESCs, activation of S6K1 pro-
motes the differentiation of these cells (Easley et al., 2010; Kawa-
some et al., 1998). mTORC1 signaling likely promotes increased
protein synthesis during ESC differentiation.
Multiple adult tissues depend upon appropriate mTORC1
signaling to regulate stem cell maintenance, proliferation, and tu-
mor suppression (Gan et al., 2008; Groszer et al., 2001; Yilmaz
et al., 2006; Zhang et al., 2006b). Increased activation of
mTORC1 in vivo quickly depletes adult neural stem cells (Bona-
guidi et al., 2011), epidermal stem cells (Castilho et al., 2009),
and HSCs (Yilmaz et al., 2006; Zhang et al., 2006b). The stem
cell depletion that occurs after Pten deletion occurs largely due
to a deleterious increase in protein synthesis, at least in the he-
matopoietic system (Signer et al., 2014). Decreasing mTORC1
activity or constitutively expressing 4E-BP1 in neonatal neural
stem cells enhances self-renewal and prevents differentiation
(Hartman et al., 2013). While mTORC1 signaling regulates the
growth of many cells, the level of mTORC1 activation varies
among different cells (Betschinger et al., 2013; Sampath et al.,
2008; Signer et al., 2014) and in the same cells over time (Chen
et al., 2009; Magee et al., 2012). This raises the possibility that
changes in mTORC1 signaling, and modulation of global protein
synthesis rates, may determine developmental changes, rather
than simply arising as a consequence of those changes.
Ribosome Assembly Influences Tissue Homeostasis
Given that differences among cells in protein synthesis, even
among lineally related cells in the same tissue, are required for
normal tissue homeostasis (e.g., Signer et al., 2014), one key
question is how these differences among cells are regulated.
Beyond differences in mTORC1 signaling, additional mecha-
nisms involving modulation of ribosomal subunit expression
and ribosome assembly also contribute to differences in protein
synthesis among cells. The heterogeneity in these mechanisms
among cells is illustrated by the cell- and tissue-specific defects
that arise as a consequence of defects in ribosome assembly.
Genes that encode individual ribosome components exhibit
great differences in expression among tissues (Kondrashov
et al., 2011) and even among cell types within the same tissue
(Signer et al., 2014). Consistent with this, mutations in genes
that encode ribosome components often have phenotypes that
are surprisingly cell type specific. In zebrafish, mutations in the
Figure 2. Signaling Pathways that Regulate Protein Synthesis
(A) Growth factors, hormones, nutrients, and stress all influence protein synthesis through complex signaling pathways (Laplante and Sabatini, 2012; Topisirovic
and Sonenberg, 2011). mTORC1 preferentially promotes the translation of a subset of mRNAs that contain complex 50 UTRs and clusters of 50 terminal oligo-
pyrimidines (TOP) or similar pyrimidine-rich sequences (Hsieh et al., 2012; Jefferies et al., 1994; Thoreen et al., 2012). These TOP genes primarily encode proteins
that promote translation, including ribosomal proteins, initiation factors, and elongation factors (Thoreen et al., 2012). While many proteins have been proposed to
regulate the translation of TOPmRNAs (Damgaard and Lykke-Andersen, 2011; Tcherkezian et al., 2014) and the translation of specific TOP containing mRNAs is
regulated in a cell-specific manner (Avni et al., 1997; Ivanov et al., 2011), the roles of these elements in stem cell maintenance and tissue homeostasis remain
unclear.
(B) The regulation of translation initiation represents the major mechanism by which cells regulate protein synthesis. The eIF4F complex, which includes eIF4E,
eIF4G, and eIF4A, promotes the translational initiation of virtually all cellular mRNAs (Sonenberg and Hinnebusch, 2009) and mRNAs with highly structured 50
UTRs are particularly sensitive to eIF4E activity (Feoktistova et al., 2013; Koromilas et al., 1992). Activated mTORC1 phosphorylates 4E-BPs, preventing their
inhibition of eIF4E. In the absence of 4E-BPs, eIF4E binds to the m7G mRNA cap and recruits eIF4G, which in turn acts as a scaffold for the RNA helicase eIF4A.
The formation of this eIF4F complex on the 50-end of mRNA promotes the initiation of cap-dependent translation. Activated mTORC1 also phosphorylates and
activates S6K, which phosphorylates eIF4B, eEF2K, and TIF1A. Phosphorylated eIF4B enhances the helicase activity of eIF4A to unwind secondary structures in
mRNA, which promotes translational initiation. Phosphorylation of eEF2K by S6K interferes with its ability to block the activity of the translational elongation factor
eEF2. Activation of TIF1A promotes ribosomal RNA transcription.
(C) The E3 ubiquitin ligase Mdm2 promotes the degradation of the tumor suppressor p53. p53 acts in a feedback loop to promote the transcription of theMdm2
gene. Thus under normal conditions, p53 levels remain low. Imbalances in ribosome biogenesis induce a tumor suppressor response in which free ribosomal
proteins, particularly Rpl5 and Rpl11, bind and inhibit Mdm2 (Bhat et al., 2004; Dai and Lu, 2004; Dai et al., 2006; Zhang et al., 2003). This results in the
accumulation of p53, which promotes the activity of TSC2, thereby repressing the activity of mTORC1. p53 and other tumor suppressors, such as ARF, inhibit
rRNA transcription and ribosome biogenesis (Lessard et al., 2010; Sloan et al., 2013; Sugimoto et al., 2003).ubiquitously expressed ribosome proteins, Rpl22 and Rpl22-like
(Rpl22l), have distinct developmental phenotypes, affecting T
lineage progenitors and HSCs, respectively (Zhang et al., 2013).
Both Rpl22 and Rpl22l compete for binding to smad1 mRNA
and have opposing effects on its translation, which partially ac-
counts for their distinct phenotypes. Similarly, rps19-deficient ze-
brafish embryos display specific defects in erythropoiesis and
cartilage development (Danilova et al., 2008), while reduced
expression of Rps29 results in erythropoietic defects and ectopic
cell death in the head (Taylor et al., 2012). The Tail short (Ts)mu-tation inmouseRpl38 causes specific skeletal defectsmarked by
reduced expression of 8 of 39 Hox proteins (Kondrashov et al.,
2011).Rpl38Tsmutations reduce the levels of 80Smonosome for-
mation on specific Hox gene transcripts. By contrast, mutations
in multiple genes that encode other ribosome components
(Rps19DSK3/+, Rps20Dsk4/+, Rpl29+/, Rpl29/, Rpl24Bst/+) do
not cause similar skeletal phenotypes or effects on Hox gene
expression (Kondrashov et al., 2011). Thus, Rpl38 plays a
specialized role in regulating the translation of specific mRNAs,
perhaps in a tissue-specific manner.Cell 159, October 9, 2014 ª2014 Elsevier Inc. 245
Human ribosome-related diseases, collectively referred to as
ribosomopathies, further reflect the preferential dependence of
specific cells on specific ribosome components. Human riboso-
mopathies include Diamond-Blackfan anemia, 5q syndrome,
Treacher Collins syndrome, Blooms and Werner syndromes,
dyskeratosis congenita, and cartilage hair hypoplasia (Armistead
and Triggs-Raine, 2014). These disorders are caused by muta-
tions in genes that encode ribosome components or genes
that affect Pol I transcription or ribosomal RNA processing (Ar-
mistead and Triggs-Raine, 2014). Each ribosomopathy exhibits
different spectrums of defects in tissue homeostasis, though he-
matopoietic and craniofacial/neural crest defects are commonly
observed (Narla and Ebert, 2010). It remains unclear why he-
matopoietic cells and neural crest cells exhibit particular sensi-
tivity to loss-of-function mutations in ribosome components or
factors required for their synthesis.
The hematopoietic defects observed as a result of mutations
in certain ribosomal components likely reflect a combination of
defects in stem cells and restricted hematopoietic progenitors.
For example, HSC function is impaired in dyskeratosis congenita
(Friedland et al., 1985; Marsh et al., 1992) and in 5Q syndrome
(Nilsson et al., 2000), whereas Diamond-Blackfan anemia ap-
pears to more strongly reflect defects in erythroid restricted pro-
genitors (Abkowitz et al., 1991; Lipton et al., 1986).
Phenotypes caused by ribosomal defects reflect a variable
combination of tumor suppressor induction along with changes
in the synthesis of key proteins (Armistead and Triggs-Raine,
2014; Barkic et al., 2009; Bellodi et al., 2010; Danilova et al.,
2008; Ludwig et al., 2014; Narla and Ebert, 2010; Taylor et al.,
2012; Zhang and Lu, 2009). Ribosome proteins can also exhibit
important functions outside the ribosome, complicating the inter-
pretation of at least some mutant phenotypes (Xue and Barna,
2012). For example, Rps13 regulates the splicing of its ownmes-
sage (Malygin et al., 2007) and ribosomes can bindmTORC2 and
promote its signaling in a translation-independent manner (Zin-
zalla et al., 2011). It remains unclear whether extraribosomal
functions are unusual properties pertaining to a minority of ribo-
some components or whether many ribosome components have
unrecognized extraribosomal functions, including cell-type-spe-
cific functions.
Ribosome assembly is also regulated differently in different
cells. Disruption of UTP4 causes North American Indian child-
hood cirrhosis (Armistead and Triggs-Raine, 2014). UTP4 is a
component of the small subunit processome, a large ribonucleo-
protein complex that promotes the maturation of 18S rRNA
(Freed and Baserga, 2010). Unique among ribosomapathies in
only affecting a single tissue, North American Indian childhood
cirrhosis first presents as childhood jaundice and progresses
to biliary cirrhosis. Knockdown of Utp4 in zebrafish also leads
to specific defects in the biliary system (Wilkins et al., 2013), sug-
gesting that the function of Utp4 in this tissue has been
conserved across species. By contrast, disruption of Notchless,
a murine ortholog of the yeast 60S subunit maturation factor
Rsa4, depletes HSCs but not more mature hematopoietic cells
(Le Bouteiller et al., 2013).
Asymmetric segregation of ribosome processing and rRNA
transcription factors influence fate determination in stem cells
and their daughter cells. The ribosomal RNA processing factor246 Cell 159, October 9, 2014 ª2014 Elsevier Inc.Wicked, a member of the conserved rRNA processing U3
snoRNP complex, exhibits asymmetric segregation during
Drosophila germline stem cell divisions (Fichelson et al., 2009).
The asymmetric distribution of Wicked during mitosis ensures
that presumptive germline stem cells inherit more of this factor
than daughters fated to differentiate. This same mode of inheri-
tance is also observed in several other stem cell populations (Fi-
chelson et al., 2009). More recent work shows that a Drosophila
Pol I regulatory factor, Under-developed (Udd), also becomes
enriched in germline stem cells relative to their differentiating
daughters (Zhang et al., 2014a). Loss of both wicked and udd
compromises germline stem cell maintenance (Fichelson et al.,
2009; Zhang et al., 2014a). The drop in Pol I activity in udd mu-
tants promotes some aspects of differentiation while expanded
rRNA transcription as a result of increased TIF-1A expression
delays differentiation (Zhang et al., 2014a). Interestingly, down-
regulation of rRNA synthesis in cultured mammalian hematopoi-
etic progenitors can also promote differentiation (Hayashi et al.,
2014). Further work will be needed to explore whether mamma-
lian lineages also exhibit asymmetric inheritance of Pol I regula-
tory and rRNA processing factors.
It will be important to compare ribosome biogenesis and
translational regulation among stem cells and their daughters
at different stages of development, in different tissues, and in
different stem cell activation states. It remains unclear whether
stem cells exhibit consistent differences relative to their differen-
tiating progeny orwhether there is asmuch diversity in regulatory
mechanisms among stem cells as among differentiated cells.
Regulated Protein Synthesis Control Suppresses
Neoplastic Proliferation
The regulation of protein synthesis promotes tissue homeostasis
partly by preventing inappropriate proliferation. Most cells in-
crease their rate of protein synthesis during cell division. Cancer
cells generally synthesize protein more rapidly and more effi-
ciently than normal cells (Ruggero, 2013). Translational control
mechanisms regulate the expression and function of a variety of
oncogenes and tumor suppressors through diverse mechanisms
(Topisirovic and Sonenberg, 2011) and cancer cells dysregulate
translation initiation to increase protein synthesis and sustain
neoplastic proliferation (Ruggero, 2013). Mechanisms that in-
crease or deregulate protein synthesis can thus promote the
development of cancer.
Mechanisms that negatively regulate protein synthesis often
suppress tumorigenesis. Key oncogenic signals, such as Myc
or PI3K pathway activation, increase protein synthesis and
change the efficiency with which subsets of mRNAs are trans-
lated (Barna et al., 2008; Hsieh et al., 2012). This is critically
important because the regulation of translation initiation, the ef-
ficiency with which mRNAs are recruited to active ribosomes,
represents the major mechanism by which cells regulate protein
synthesis. Based on studies of cancer cells (Hsieh et al., 2012), it
seems likely that there are differences among stem cells and
restricted progenitors in terms of how they regulate translation
initiation, though this has not yet been studied.
Genetic changes or pharmacological agents that reduce pro-
tein synthesis can impede cancer development and progression
(Barna et al., 2008; Hsieh et al., 2010; Hsieh et al., 2012; Signer
Figure 3. Differences in the Regulation of Protein Synthesis among
Cells
(A) Cells respond to changes in nutrient levels by altering protein synthesis,
ribosome biogenesis (Laplante and Sabatini, 2012), and protein degradation
(Zhang et al., 2014b) by modulating mTORC1 signaling.
(B) Embryonic stem cells (ESCs) and adult hematopoietic stem cells (HSCs)
exhibit lower levels of protein synthesis than their differentiating progeny.
Whether other stem cell lineages display similar changes in protein synthesis
upon differentiation will require further analysis. One intriguing possibility is
that this property may vary among stem cells, depending on their cell-cycle
kinetics and whether they are long-lived or short-lived in vivo.
(C) Tissue homeostasis depends on a balance between proto-oncogenes and
tumor suppressors. Tumor suppressors such as PTEN and p53 reduce cellular
growth and proliferation through a number of different mechanisms, including
decreasing mTORC1 activity and reducing global protein synthesis (Laplante
and Sabatini, 2012). Proto-oncogenes, including Myc and Ras, increase pro-
tein translation and ribosome biogenesis, fueling growth and proliferation.
Cells transform to cancer when mutations reduce tumor suppressor function
or increase oncogene function (van Riggelen et al., 2010).et al., 2014). Moreover, a number of tumor suppressors nega-
tively regulate protein synthesis, for example by negatively regu-
lating mTORC1 signaling (Laplante and Sabatini, 2012). Tumor
suppressors can thus regulate protein synthesis through a vari-
ety of mechanisms.
Mutations in ribosome biogenesis factors or ribosome compo-
nents impair tissue homeostasis and promote the development
of cancer through diverse mechanisms. For example, in X-linked
dyskeratosis congenita, disruption of dyskerin (DKC1), an
enzyme that pseudouridylates rRNA (Ni et al., 1997), leads to
bone marrow failure, skin abnormalities, various carcinomas,
and acute myeloid leukemia (Heiss et al., 1998; Ruggero et al.,
2003). DKC1 mutations do not affect global protein synthesis
but do reduce the translation of a subset of mRNAs with IRES el-
ements in their 50 UTRs (Yoon et al., 2006), including the p53 and
p27 tumor suppressors (Bellodi et al., 2010). Thus, one mecha-
nism by which mutations in ribosome components and biogen-
esis factors promote the development of cancer is through
effects on the translation of tumor suppressors. To the extent
that ribosomopathies induce proteotoxic stress or a tumor sup-
pressor response, they may also create a selective pressure to
inactivate tumor suppressors in normal cells that are engaged
in tissue regeneration, increasing the probability of subsequent
transformation.
Tumor suppressor responses may be induced by sustained
oncogenic stimuli as a consequence of their effects on protein
synthesis. Diverse oncogenic stimuli induce tumor suppressor
responses in a wide range of normal cells (Collado and Serrano,
2010). A series of studies suggest that cells may sense onco-
genic stimuli based on their effects on protein synthesis. Multiple
distinct mutations in ribosomal proteins induce the accumulation
of p53, as do defects in ribosomal biogenesis and nucleolar
stress (Armistead and Triggs-Raine, 2014; Barkic et al., 2009;
Bellodi et al., 2010; Danilova et al., 2008; Narla and Ebert,
2010; Taylor et al., 2012; Zhang and Lu, 2009). For example,
disruption of Rps14 activates p53 and loss of p53 rescues the
hematopoietic progenitor cell depletion observed in these mu-
tants (Barlow et al., 2010; Dutt et al., 2011). p53 expression in-
creases in response to defects in ribosome biogenesis, partly
as a consequence of Mdm2 binding by ribosomal components
(such as Rpl5 and Rpl11) (Bhat et al., 2004; Dai and Lu, 2004;
Dai et al., 2006; Zhang et al., 2003), suggesting that disruption
of the normal stoichiometry of ribosome assembly leads to the
sequestration of Mdm2 by free ribosomal proteins (Figure 2C).
The efficiency of reprogramming of somatic cells to pluripo-
tency by Sox2, Myc, Klf4, and Oct4 (all of which are oncogenes)
is limited partly by p53 and p16Ink4a/p19Arf tumor suppressor
expression (Kawamura et al., 2009; Li et al., 2009; Mario´n
et al., 2009; Utikal et al., 2009). An important recent paper by So-
nenberg and colleagues demonstrates that loss of 4E-BP1/2 im-
pairs the reprogramming of fibroblasts to pluripotent stem cells,
partly by inducing the expression of the p21cip1 tumor suppres-
sor (Tahmasebi et al., 2014). However, in the absence of p53,
loss of 4E-BP1/2 promotes reprogramming. Since 4E-BPs are
negative regulators of translation, these data suggest protein
synthesis must increase for successful reprogramming, but
that this induces a tumor suppressor response that reduces re-
programming efficiency.Cell 159, October 9, 2014 ª2014 Elsevier Inc. 247
Tumor suppressors can also be induced in response to
changes in the quality of the proteome, such as in an unfolded
protein response. Increased protein synthesis can overwhelm
the chaperone system and lead to the accumulation of misfolded
proteins that aggregate and impede diverse cellular processes
(Back et al., 2009; Schro¨der and Kaufman, 2005). Induction of
an unfolded protein response reduces protein synthesis and in-
creases proteasome activity and tumor suppressor expression.
The unfolded protein response reduces the number of active
polysomes through eIF2a phosphorylation, allowing free ribo-
somal proteins to associate with Mdm2, stabilize p53, and
induce cell-cycle arrest (Zhang et al., 2006a). Thus, cellular sur-
veillance of protein synthesis and protein quality is achieved
through diverse mechanisms that induce tumor suppressors,
influencing tissue homeostasis and neoplastic proliferation.Perspective
Stem cell function and tissue homeostasis are regulated by net-
works of proto-oncogenes and tumor suppressors that feature
key transcriptional regulators that distinguish stem cells from
their progeny (He et al., 2009). While these networks have
been understood to regulate cell identity, signal transduction,
transcription, and cell-cycle progression, other areas of cellular
physiology continue to be of uncertain relationship to cellular
identity. It is likely that many of these aspects of cellular physi-
ology exhibit much more cellular specificity in their regulation
than currently appreciated. Consistent with this, protein synthe-
sis is regulated differently in different kinds of cells and these dif-
ferences are critical for fate determination and the maintenance
of tissue homeostasis (Figure 3). These functions are necessarily
and intimately intertwined with the role of translational regulation
in tumor suppression. The ability of translational regulation to
suppress the development of cancer reflects its role in prevent-
ing inappropriate proliferation by stem cells and other cells within
normal tissues. As our understanding of translational regulation
matures, new biology will emerge, marked by unanticipated reg-
ulatory mechanisms.ACKNOWLEDGMENTS
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